p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.

Cutilli, T

p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation. [electronic resource] - Journal of chemotherapy (Florence, Italy) Oct 1998 - 411-7 p. digital

Publication Type: Journal Article

1120-009X

10.1179/joc.1998.10.5.411 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Combined Modality Therapy
Facial Neoplasms--drug therapy
Fluorouracil--administration & dosage
Genes, ras
Humans
Immunohistochemistry
Jaw Neoplasms--drug therapy
Mutation
Neoadjuvant Therapy
Prognosis
Treatment Outcome
Tumor Suppressor Protein p53--biosynthesis